Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyur Patel

Showing results (261-270 of 357) with videos related to

Pageof 36
Sort By:
World Journal of Gastroenterology|December 8, 2011
FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virusKeyur Patel, Mireen Friedrich-Rust, Yoav Lurie, et al.
Gastroenterology|December 17, 2009
Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infectionJohn McHutchison, Zachary Goodman, Keyur Patel, et al.
Clinical Science (London, England : 1979)|January 21, 2014
Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replicationSteve S Choi, Lee C Claridge, Ravi Jhaveri, et al.
Leukemia & Lymphoma|December 20, 2024
Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation: report of two cases with literature reviewKaren Amelia Nahmod, Roberto N Miranda, Francisco Vega, et al.
Hepatology (Baltimore, Md.)|February 15, 2012
Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic responseSusanna Naggie, Anu Osinusi, Antonios Katsounas, et al.
The American Journal of Cardiology|August 22, 2017
Sleep-Disordered Breathing and Cardiovascular Correlates in College Football PlayersJonathan H Kim, Casey Hollowed, Morgan Irwin-Weyant, et al.
American Journal of Hematology|August 25, 2015
Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decadeTalha Badar, Hagop M Kantarjian, Graciela M Nogueras-Gonzalez, et al.
Diabetes Care|September 16, 2016
Pancreatic Safety of Sitagliptin in the TECOS StudyJohn B Buse, M Angelyn Bethel, Jennifer B Green, et al.
Cancer|July 28, 2016
TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomesTapan M Kadia, Preetesh Jain, Farhad Ravandi, et al.
Blood Cancer Journal|May 6, 2020
Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemiaIman Abou Dalle, Ahmad Ghorab, Keyur Patel, et al.
Pageof 36

Showing results (261-270 of 357) with videos related to

Sort By:
Pageof 36
World Journal of Gastroenterology|December 8, 2011
FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virusKeyur Patel, Mireen Friedrich-Rust, Yoav Lurie, et al.
Gastroenterology|December 17, 2009
Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infectionJohn McHutchison, Zachary Goodman, Keyur Patel, et al.
Clinical Science (London, England : 1979)|January 21, 2014
Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replicationSteve S Choi, Lee C Claridge, Ravi Jhaveri, et al.
Leukemia & Lymphoma|December 20, 2024
Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation: report of two cases with literature reviewKaren Amelia Nahmod, Roberto N Miranda, Francisco Vega, et al.
Hepatology (Baltimore, Md.)|February 15, 2012
Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic responseSusanna Naggie, Anu Osinusi, Antonios Katsounas, et al.
The American Journal of Cardiology|August 22, 2017
Sleep-Disordered Breathing and Cardiovascular Correlates in College Football PlayersJonathan H Kim, Casey Hollowed, Morgan Irwin-Weyant, et al.
American Journal of Hematology|August 25, 2015
Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decadeTalha Badar, Hagop M Kantarjian, Graciela M Nogueras-Gonzalez, et al.
Diabetes Care|September 16, 2016
Pancreatic Safety of Sitagliptin in the TECOS StudyJohn B Buse, M Angelyn Bethel, Jennifer B Green, et al.
Cancer|July 28, 2016
TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomesTapan M Kadia, Preetesh Jain, Farhad Ravandi, et al.
Blood Cancer Journal|May 6, 2020
Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemiaIman Abou Dalle, Ahmad Ghorab, Keyur Patel, et al.
Pageof 36